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Abstract: The free radical theory of aging hypothesizes that oxygen-derived free radicals are 
responsible for the age-related damage at the cellular and tissue levels. In a normal situation, a 
balanced-equilibrium exists among oxidants, antioxidants and biomolecules. Excess generation 
of free radicals may overwhelm natural cellular antioxidant defences leading to oxidation and 
further contributing to cellular functional impairment. The identiﬁ  cation of free radical reactions 
as promoters of the aging process implies that interventions aimed at limiting or inhibiting them 
should be able to reduce the rate of formation of aging changes with a consequent reduction 
of the aging rate and disease pathogenesis. Even if antioxidant supplementation is receiving 
growing attention and is increasingly adopted in Western countries, supporting evidence is still 
scarce and equivocal. Major limitations in literature are still needed to be addressed to better 
evaluate the potential beneﬁ  ts from antioxidant supplementation: 1) an improved understand-
ing of oxidation mechanisms possibly at the basis of the aging process, 2) the determination of 
reliable markers of oxidative damage and antioxidant status, 3) the identiﬁ  cation of a therapeu-
tic window in which an eventual antioxidant supplementation may be beneﬁ  cial, 4) a deeper 
knowledge of the antioxidant molecules which in several conditions act as pro-oxidants.In the 
present paper, after a preliminary introduction to the free radical theory of aging and the ratio-
nale of antioxidant supplementation as an anti-aging intervention, we will present an overview 
of evidence relating antioxidant supplementations with clinical conditions typical of older age 
(ie, cardiovascular disease, Alzheimer’s disease, cancer). We will also discuss studies that have 
evaluated whether antioxidant supplementation might improve major outcomes of interest in 
older persons (ie, physical performance, muscle strength, longevity). Given the large amount 
of data available on the antioxidant supplementation topic, this overview is not intended to be 
exhaustive. The aim of this paper is to provide the main basis from which future studies should 
start and indicate which the main limitations that need to be addressed are.
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The free radical theory of aging
More than 300 theories have been proposed to explain the ageing process (Medvedev 
1990), but none has yet been generally accepted by gerontologists. However, the initial 
proposal by Denham Harman that free radicals are causally related to the basic aging 
process (Harman 1957) is receiving growing acceptance as a possible explanation of 
the chemical reactions at the basis of ageing (De La Fuente 2002). The free radical 
theory of aging hypothesizes a single common process, modiﬁ  able by genetic and 
environmental factors, in which oxygen-derived free radicals are responsible (due to 
their high reactivity) for the age-associated damage at the cellular and tissue levels. 
In fact, the accumulation of endogenous oxygen radicals generated in cells and the 
consequent oxidative modiﬁ  cation of biological molecules (lipids, proteins and nucleic 
acid) have been indicated as responsible for the aging and death of all living beings 
(Finkel and Holbrook 2000; Harman 1957).Clinical Interventions in Aging 2007:2(3) 378
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The free radical theory was revised in 1972 (Harman 1972) 
when mitochondria were identiﬁ  ed as responsible for the initia-
tion of most of the free radical reactions occurring in the cells. It 
was also postulated that the life span is determined by the rate of 
free radical damage to the mitochondria. In fact, mitochondria, in 
which there is a continuous generation of free radicals throughout 
cell life, and especially mitochondrial DNA, are key targets of 
the free radical attack. Cells which use oxygen, and consequently 
produce reactive oxygen species, had to evolve complex anti-
oxidant defence systems to neutralize reactive oxygen species 
and protect themselves against free radical damage. Thus, the 
increasing oxidative stress in ageing seems to be a consequence 
of the imbalance between free radical production and antioxidant 
defences with a higher production of the former (Sastre et al 
2000). An ideal “golden triangle” of oxidative balance, in which 
oxidants, antioxidants and biomolecules are placed at each apex, 
has been described (Carmeli et al 2002). In a normal situation, a 
balanced-equilibrium exists among these three elements. Excess 
generation of free radicals may overwhelm natural cellular an-
tioxidant defences leading to oxidation and further contributing 
to cellular functional impairment (Bowles et al 1991; Meydani 
et al 1993).
The identiﬁ  cation of free radical reactions as promoters of 
the aging process implies that interventions aimed at limiting 
or inhibiting them should be able to reduce the rate of forma-
tion of aging changes with a consequent reduction of the aging 
rate and disease pathogenesis (Harman 2003). In fact, the free 
radical theory of aging fostered a important body of research 
investigating the potential role of antioxidant nutrients in thera-
peutic or preventive strategies (Mayne 2003). However, even 
if antioxidant supplementation is receiving growing attention 
and is increasingly adopted in Western countries, supporting 
evidence is still scarce and equivocal.
Oxidative damage
The simplest free radical is an atom of the element hydrogen, 
with one proton and a single electron. Free radicals may also 
be nitrogen- or carbon-centered but O2-centered radicals 
are the most important ones in aerobic organisms. Reactive 
oxygen species are mainly produced in mitochondria, which 
utilize most of the O2 consumed for substrate metabolism 
and ATP production, reducing O2 to water. Reactive oxy-
gen species, produced under normal aerobic metabolism, 
are essential for cell signalling and for bacterial defence. In 
respiring cells, there appears to be a leakage of electrons from 
the mitochondrial electron transport chain, to eventually yield 
a variety of such free radicals and active oxygen derivatives 
that are collectively called reactive oxygen species.
Under normal conditions about 1% of reactive oxygen 
species daily escapes the control of the endogenous anti-
oxidant defences and contributes to oxidative damage of 
surrounding tissues, consequently promoting and developing 
the aging process. Reactive oxygen species can attack any 
biochemical component of the cell. If the body or cell capac-
ity to neutralise reactive oxygen species is altered, then they 
will produce acute damage to vital proteins, lipids and DNA. 
In humans, unbalance between reactive oxygen species pro-
duction and endogenous antioxidants has been involved in the 
generation or worsening of more than a hundred pathologic 
conditions (Gutteridge 1993).
Measuring the free radical activity in vivo (ie, increased 
reactive oxygen production) is confronted with practical and 
analytical problems: we are left with the surrogate determina-
tions of the end products of oxidation. In fact, the oxidative 
damage is commonly determined by the quantity of nucleic 
acid that is damaged with the Comet assay (Hartmann et 
al 2003), the amount of end products of lipid peroxidation 
(Cesari et al 2005; Sakamoto et al 2002), or of protein oxida-
tion (Cesari et al 2005).
Physical activity and oxidative 
damage
The increased production of free radicals during physical exercise 
has been attributed to several factors, including the increase of 
catecholamines undergoing auto-oxidation, muscle transient 
hypoxia and re-oxygenation, lactic acid-induced free iron release 
from myoglobin, and/or inﬂ  ammation-related neutrophil func-
tion (Ji et al 1998). There is a substantial lack of data regarding 
the effects of acute or chronic exercise in aging animals or 
humans. Inconsistent results (partly also due to methodological 
limitations in the reactive oxygen species measurements) do not 
allow a clear interpretation of studies regarding exercise-related 
DNA and protein oxidation, and lipid peroxidation. However, 
current literature seems to show an increased resistance to oxi-
dative damage with chronic exercise and increased lipid, DNA 
or protein oxidation after an acute bout of maximal exercise 
(Polidori et al 2000).
Regular physical activity and exercise are recommended 
for the maintenance of an optimal health status and the pre-
vention or management of chronic diseases (Department of 
Health and Human Services, Centers for Disease Control 
and Prevention, and National Center for Chronic Disease 
Prevention and Health Promotion 1996; Pate et al 1995). 
Physical activity (especially if begun in mid-life), quitting 
cigarette smoking, maintaining normal blood pressure, and 
avoiding obesity are independently associated with reduced Clinical Interventions in Aging 2007:2(3) 379
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cardiovascular and overall mortality (Paffenbarger et al 
1993). Regular physical activity has shown to reverse age-re-
lated body composition modiﬁ  cations in older subjects (ie, by 
increasing lean mass and reducing adipose tissue) (Fiatarone 
Singh 1998; Fiatarone et al 1994; Polidori et al 2000), and 
to confer signiﬁ  cant protection against several age-related 
diseases (eg, non-insulin-dependent diabetes (Hughes et al 
1995); cancer (Ji et al 1991); hypertension (Dengel et al 
1998); and osteoporosis (Evans 1999)).
Animal (Zerba et al 1990) as well as human (Quindry 
et al 2003; Tozzi-Ciancarelli, Penco and Di Massimo 2002; 
Watson et al 2005) models have demonstrated that acute 
bouts of eccentric exercise produce higher oxidative damage 
to muscles in aged mice and men compared to young animals 
or human subjects. However, physical activity may still play 
an important role in limiting the free radical production and 
oxidative damage. In fact, even if exercise is associated with 
an abnormal production of free radicals, physically active older 
persons beneﬁ  t from exercise-induced adaptations in the cel-
lular antioxidant defence systems (Fulle et al 2004).
Physical exercise may lead to an increase in antioxidant 
defences of the organism in younger as well as in older subjects 
(Lawler and Powers 1998; Leeuwenburgh and Heinecke 2001). 
Nevertheless, the equilibrium between free radical produc-
tion and antioxidant defence induction by physical exercise 
intervention in elders may be more unstable than in younger 
subjects. This is probably due to the higher rate of oxidative 
stress occurring in older persons (Ames 1989; Facchini et al 
2000; Greco et al 2000; Olinski et al 2003), partly explained by 
increased number of concurrent clinical conditions and the sed-
entary lifestyle. Moreover, although age-related modiﬁ  cations 
occurring in antioxidant defences and repairing systems are 
not yet fully clariﬁ  ed (Beckman and Ames 1998), a decrease 
of major antioxidants levels with aging has been suggested 
(Pinzani et al 1997; Poulsen et al 1996).
An acute bout of exercise increases antioxidant activities in 
skeletal muscle, heart, and liver with a threshold and magnitude 
of activation that differs among antioxidant enzymes, tissues, 
and type of exercise organisms (Ji et al 1998). No signiﬁ  cant 
difference in the antioxidant enzyme response between old and 
young animals has been suggested (Fiebig et al 1994; Ji 1996; 
Lawler and Powers 1998). Moreover, endurance training has 
shown to increase antioxidant enzyme activities even in the 
senescent muscle (Ji et al 1991).
Antioxidants
Antioxidants are substances, which inhibit or delay oxidation 
of a substrate while present in minute amounts. Endogenous 
antioxidant defences are both non-enzymatic (eg, uric acid, 
glutathione, bilirubin, thiols, albumin, and nutritional fac-
tors, including vitamins and phenols) and enzymatic (eg, the 
superoxide dismutases, the glutathione peroxidases [GSHPx], 
and catalase). In the normal subject the endogenous antioxi-
dant defences balance the reactive oxygen species produc-
tion, but for the above-mentioned 1% daily leak. The most 
important source of antioxidants is provided by nutrition, 
many belonging to the phenol family.
Nutritional antioxidants act through different mechanisms 
and in different compartments, but are mainly free radical scav-
engers: 1) they directly neutralise free radicals, 2) they reduce 
the peroxide concentrations and repair oxidized membranes, 3) 
they quench iron to decrease reactive oxygen species produc-
tion, 4) via lipid metabolism, short-chain free fatty acids and 
cholesteryl esters neutralise reactive oxygen species (Berger 
2005). The body antioxidant defence can be approximated by 
measuring antioxidant plasma levels (micronutrients, enzymes, 
other antioxidant), keeping in mind that the circulating com-
partment only reﬂ  ects the ﬂ  ow between organs and tissues. 
The tissue levels of the various antioxidants remains limited 
to research protocols as tissue biopsies are required.
Vitamin C is the major water-soluble antioxidant and acts 
as ﬁ  rst defence against free radicals in whole blood and plasma. 
It is a powerful inhibitor of lipid peroxidation and regenerates 
vitamin E in lipoproteins and membranes. A strong inverse 
association has been shown between plasma ascorbic acid 
and isoprostanes (Block et al 2002). Isoprostanes represent a 
family of prostaglandin isomers which, in contrast to classic 
prostaglandins formed through an enzymatic action of the 
prostaglandin-H-synthase from arachidonic acid, result from 
a free radical-catalyzed mechanism (Morrow et al 1990). For 
this reason, isoprostanes provide an optimal estimate of oxida-
tive damage to cellular lipids (Morrow 2005) and represent 
an excellent biomarker of lipid peroxidation for aging studies 
(Cesari et al 2005).
Bagi et al (Bagi et al 2003) have shown that chronic 
vitamin C treatment is able to decrease high levels of 
isoprostanes in animal models. Ascorbic acid combined to 
α-tocopherol is particularly effective in inhibiting oxida-
tion (Niki et al 1995). Vitamin C reduces α-tocopheroxyl 
radicals rapidly in membranes and LDL to regenerate α-
tocopherol and possibly inhibits α-tocopheroxyl radical-
mediated propagation.
Vitamin E is a lipid-soluble vitamin found in cell mem-
branes and circulating lipoproteins. It protects against oxidative 
damage by acting directly with a variety of oxygen radicals. 
Its antioxidant function is strongly supported by regeneration Clinical Interventions in Aging 2007:2(3) 380
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promoted by vitamin C (Maxwell 1995). Vitamin E is thought 
to have a role in the prevention of atherosclerosis through 
inhibition of oxidative modiﬁ  cations of LDLs (Steinberg 
1997; Witztum 1994). The formation of isoprostanes increases 
signiﬁ  cantly in animals deﬁ  cient in vitamin E (Morrow and 
Roberts 1997). Moreover, inhibition of isoprostanes forma-
tion by vitamin E supplementation has been shown in humans 
(Upritchard et al 2003) as well as in animal models (Liu et al 
1999). α-tocopherol is quantitatively the major form of vitamin 
E in humans and has been extensively studied. In contrast, 
γ-tocopherol, even if representing the most abundant form 
of vitamin E in the US diet, has received less attention (Jiang 
et al 2001). Compared with α-tocopherol, γ-tocopherol is a 
slightly less potent antioxidant with regard to electron-donat-
ing propensity, but is superior in detoxifying electrophiles, 
such as reactive nitrogen oxide species (Jiang et al 2001). The 
interaction of α-tocopherol with β-carotene is not as evident 
as the one reported with vitamin C, but it has been shown 
that α-tocopherol and β-carotene exert a cooperative effect 
by residing and scavenging radicals at different positions in 
the lipophilic compartment (Niki et al 1995).
Carotenoids are lipid-soluble antioxidants. Plasma 
levels of carotenoids are negatively correlated with levels 
of isoprostanes (Block et al 2002). Carotenoids levels are 
inversely associated with inﬂ  ammation (Hu et al 2004), 
atherosclerosis (Prince et al 1988), cardiovascular disease 
(Gaziano et al 1995), sarcopenia (Semba et al 2003), and 
mortality (Hu et al 2004), and positively correlated with 
physical performance (Cesari et al 2004). Improvements in 
antioxidant status and reduction of lipid peroxidation have 
been shown after carotenoids supplementation (Upritchard 
et al 2003). The most known and studied carotenoid is the 
β-carotene, a potent antioxidant able to quench singlet oxy-
gen rapidly (Di Mascio et al 1991). β-carotene, α-carotene, 
β-cryptoxanthin, lycopene, and lutein/zeaxanthin have all 
been found associated with inﬂ  ammation (Hu et al 2004; 
Kritchevsky et al 2000). The association between low serum 
levels of β-carotene and increased risk for mortality was 
recently reported (Hu et al 2004).
Vitamin C, vitamin E, and carotenoids have shown to 
synergistically interact against lipid peroxidation (Niki et al 
1995). Higher serum levels of antioxidants are associated 
with higher strength and physical performance measures 
(Cesari et al 2004; Semba et al 2003), suggesting that oxida-
tive damage may play an important role for the onset of the 
disabling process.
Melatonin is a mammalian hormone synthesized from 
serotonin, mainly in the pineal gland. Besides of its widely 
documented action regulating the circadian rhythm, it has 
been reported that melatonin contributes to the reduction 
of oxidative damage in both the lipid and the aqueous 
environments of the cell (Aydogan et al 2006). The powerful 
antioxidant capacity of melatonin (Pieri et al 1995) is exerted 
by stimulating the expression and activity of glutathione 
peroxidase, superoxide dismutase, NO synthetase (Nishida 
2005). Interestingly, melatonin concentrations are particu-
larly high in mitochondria and the cell nucleus (Aydogan 
et al 2006), where major oxidation reactions occur.
The balance between oxidant and reducing forces is 
subtle (Abuja 1998). Trace elements with antioxidant prop-
erties such as copper and selenium (Terada et al 1999), may 
become strongly pro-oxidant both in vivo and in vitro, as a 
consequence of their physical properties. This is also the 
case with vitamins A, C, E, which may become pro-oxidant 
under deﬁ  ned conditions (Berger 2005).
Vitamin E can also become a pro-oxidant in isolated 
lipoprotein suspensions (eg, parenteral nutrition solutions 
in clinical conditions (Neuzil et al 1995). The pro-oxidant 
effects of selenium have been investigated on cultured vas-
cular cells exposed to parenteral nutrition containing vari-
ous forms and quantities of selenium (Terada et al 1999). 
In a recent study, Nakamura and colleagues (Nakamura 
et al 2006) suggested that Vitamin C may play an important 
role to prevent the pro-oxidant effect of Vitamin E in LDL 
oxidation.
Antioxidant supplementation
The last 50 years have been characterized by the understanding 
of the impact of nutrition and dietary patterns on health 
(Caballero 2003). An important part of the population is 
exposed to the risk of trace element and vitamin deﬁ  ciency 
for multiple reasons (eg, changes in eating habits in Western 
Countries, lower food concentration of micronutrients 
due to intensive agricultural techniques). Children, young 
women and elders are the most exposed (Caballero 2002; 
Johnson et al 2002; Ramakrishnan 2002). Efforts to ﬁ  ght 
nutrient deﬁ  ciencies have centred on supplemental nutrient 
administration and on addition of selected nutrients to the 
food chain in the form of food fortiﬁ  cation (Caballero 2003). 
Supplementation and fortiﬁ  cation has also been proposed 
in healthy individuals with the aim of reducing their risk of 
future diseases (eg, cardiovascular diseases, diabetes and 
cancer). Nevertheless, with our increasing understanding of 
the genetic heterogeneity of human nutrient requirements, it 
is likely that certain groups or even populations may beneﬁ  t 
from higher intakes of certain nutrients. However, the latter Clinical Interventions in Aging 2007:2(3) 381
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concept is getting closer to the therapeutic modulation of 
nutrient intake.
Antioxidant supplementation 
and clinical conditions
Atherosclerosis and cardiovascular 
disease
In Western Countries, atherosclerotic disease is the 
major cause of death in the elderly population. Several 
antioxidants, such as polyphenols and lycopene, have 
been proposed to delay the progression of this disease. 
At the beginning of the Nineties, Renaud and de Lor-
geril created the so-called “French Paradox”, describing 
how, despite the high intake of saturated fat, the French 
population presents a low incidence of coronary heart 
disease events (Renaud and de Lorgeril 1992). Even if 
their study raised a huge controversy, it has been sug-
gested that beneficial effects from red wine consumption 
might be related to its high content of antioxidants (Heller 
et al 1998). Resveratrol, a phytoalexin found in several 
plants (in particular, red grapes), has shown to be able to 
up-regulate the nuclear Liver X receptor α and its target 
genes in macrophages, and to reduce the expression of 
lipoprotein lipase and scavenger receptor AII (Sevov et al 
2006). Through these mechanisms, resveratrol seems to 
limit cholesterol accumulation in human macrophages. 
A recent study conducted in cultured human coronary 
artery endothelial cells has also demonstrated a beneficial 
effect of polyphenols (ie, catechin and quercetin) on the 
expression of the plasminogen activator inhibitor-1 gene, 
potentially providing a further biological explanation 
to the cardiovascular protective role of these molecules 
(Pasten et al 2007). However, no definite conclusion can 
still be drawn given the complex mechanisms in which 
polyphenols (eg, resveratrol) are involved and which 
may influence the net results of their supplementation 
(Iannelli et al 2006).
A number of prospective cohort studies and case-control 
studies have reported that increased intake of dietary anti-
oxidants including vitamin E, vitamin C, and β-carotene, 
are associated with reduced risk of atherosclerotic diseases 
(Kaliora et al 2006). Thus, antioxidants seem to prevent the 
development and progression of arteriosclerosis (Nakamura 
et al 2006). From this evidence, a growing interest has 
been posed into antioxidants as potential inhibitors of the 
proatherogenic and prothrombotic oxidative events occur-
ring in the artery wall and underlying the atherosclerotic 
process. In 1999, an American Heart Association Science 
Advisory recommended that the general population con-
sume a balanced diet with emphasis on antioxidant-rich 
fruits, vegetables, and whole grains (Krauss et al 2000). 
Given the absence of data from randomized, controlled 
clinical trials at the time, no recommendations were made 
regarding the use of antioxidant supplementation. In a more 
recent American Heart Association Science Advisory (Kris-
Etherton et al 2004), current evidence about the beneﬁ  cial 
effects of antioxidant vitamins (such as vitamin E, vitamin 
C, and β-carotene) on cardiovascular risk has been revised 
and discussed. Consistently with previous recommenda-
tions from the American Heart Association (Mosca et al 
2004) and the American College of Cardiology (Gibbons 
et al 2003), scientiﬁ  c data do not yet justify the use of 
antioxidant vitamin supplements for cardiovascular risk 
reduction. However, the controversial results on this topic 
require further research.
A recent randomized controlled trial, enrolling more 
than 35,000 healthy women aged 45 years and older, 
showed no beneficial effect from vitamin E supplementa-
tion (600 IU on alternate days for a mean of 10.1 years) 
for the prevention of major cardiovascular events, cancer, 
total mortality, and cardiovascular mortality (Lee et al 
2005). Similar results were also obtained from the HOPE 
and the HOPE-TOO trials (The HOPE and HOPE-TOO 
Trial Investigators 2005), where a possible increased risk 
of heart failure was also hypothesized in the intervention 
group (vitamin E 400 IU daily).
Recently, Pham and Plakogiannis (Pham and Plakogiannis 
2005) have reviewed evidence on the effects of vitamin E 
supplementation and cardiovascular and cancer prevention. 
Their meta-analysis showed that contradicting results 
regarding the beneﬁ  ts of vitamin E in the prevention of 
cardiovascular disease and cancer from the considered stud-
ies. Authors assured the presence of adequate evidence from 
large, well-designed studies to discourage the use of vitamin 
E in the primary prevention of cardiovascular disease. For 
what concerns secondary prevention, more adequate clini-
cal trials with selected populations are required to examine 
protective effects of vitamin E in cardiovascular disease.
It is important to underline how positive ﬁ  ndings are 
mostly from observational studies, so that the relationship 
between vitamin E supplementation (the most promising 
antioxidant in the prevention of atherosclerotic disease) and 
lower rates of cardiovascular disease may just reﬂ  ect an over-
all healthy lifestyle and dietary intake of supplement users 
rather than a real protective effect. Nevertheless, a role for Clinical Interventions in Aging 2007:2(3) 382
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oxidative mechanisms underlying the human atherosclerosis 
pathogenesis can not be ruled out.
Alzheimer’s disease
A number of studies have shown that aging and particularly 
brain aging are associated with free radicals action. Evidence 
suggests that reactive oxygen species in brain may play a role 
in the development of age-related neuronal impairments. The 
increase in the concentration of the pro-inﬂ  ammatory cytokines 
in aged brain tissue may also represent a contributory factor.
The accumulation of oxidative damages to neuronal 
components with age underlies the molecular basis of brain 
aging and neurodegeneration (Kolosova et al 2006). Oxida-
tive stress has been implicated in mechanisms leading to 
neuronal cell injury in various pathological states of the brain 
(Calabrese et al 2003).
Alzheimer’s disease is a progressive disorder with cogni-
tive and memory decline, speech loss, personality changes 
and synapse loss. The heterogeneity of the etiologic factors of 
Alzheimer’s disease makes it difﬁ  cult to deﬁ  ne the major clini-
cal determinants for the onset and progression of the disease. 
However, increasing evidence has recently indicated oxidative 
damage as a potential cause of Alzheimer’s disease pathogenesis 
(Nunomura et al 2006; Onyango and Khan 2006). Moreover, 
subjects with dementia attributed to Alzheimer’s disease have 
shown an altered balance between oxidant and antioxidant levels 
(Sinclair et al 1998). Recently, increasing interest has been fo-
cused on identifying dietary compounds that can inhibit, retard 
or reverse the multi-stage pathophysiological events underly-
ing Alzheimer’s disease pathology. Alzheimer’s disease also 
involves a chronic inﬂ  ammatory response associated with both 
brain injury and beta-amyloid associated pathology.
Animal models have demonstrated that dietary supple-
mentation with antioxidant vitamins can prevent or reverse 
the age-related changes in antioxidant defences in the central 
nervous system and decrease oxidative stress (O’Donnell 
and Lynch 1998). In a recent review, Vina and colleagues 
(Vina et al 2004) demonstrate that the cognitive function in 
Alzheimer’s disease patients is inversely correlated with sys-
temic oxidative stress. They also conﬁ  rm the idea that vitamin 
E may be considered as an effective treatment of Alzheimer’s 
disease. However, the effect of vitamin E on Alzheimer’s 
disease patients shows considerable variations both in its 
antioxidant function and in its capacity to improve cognitive 
functions. Therefore, consistently with previous recommenda-
tions (Kris-Etherton, and for the Nutrition Committee of the 
American Heart Association Council on Nutrition Physical 
Activity and Metabolism 2004), Authors suggest that the 
determination of the oxidant-antioxidant status of the patient 
is particularly important to test the effect of antioxidants on 
given functions.
A major limitation present in most of the intervention 
studies exploring the effects of antioxidants supplementa-
tion (eg, vitamin E) on Alzheimer’s disease outcomes is 
that they have been conducted on subjects who already 
have been diagnosed with this clinical condition. There-
fore, it is difﬁ  cult to assess the full potential of the speciﬁ  c 
substances in the prevention of Alzheimer’s disease. More-
over, antioxidants are often tested as single agents, while it 
is becoming clearer that combinations of antioxidants are 
more effective. As for evidence related to cardiovascular 
disease, a large part of studies on the topic (mostly from 
epidemiologic reports) has shown that individuals, who 
consume higher amounts of fruits and vegetables, as well as 
vitamin supplement users, have lower rates of Alzheimer’s 
disease. Some reports have suggested that combinations of 
vitamins with antioxidant properties (in particular, vitamin 
C and vitamin E) have shown the greatest beneﬁ  ts (Frank 
and Gupta 2005).
Cancer
While the exact role of free radicals in carcinogenesis and 
cancer progression is still under investigation, increasing 
evidence has demonstrated that some antioxidants are 
associated with a lower incidence of speciﬁ  c types of can-
cers. Vitamin E, for example, has been shown in some trials 
to reduce the incidence of breast, lung, and colon cancers, 
but the most signiﬁ  cant results have been obtained with 
prostate cancer. For example, in the the alpha-tocopherol 
beta-carotene cancer prevention study (Albanes et al 1995), 
in which the participants were all male smokers, α-tocoph-
erol supplementation decreased prostate cancer incidence 
and mortality. Recently, the supplementation en vitamines et 
mineraux antioxydants (SU.VI.MAX) study, a randomised, 
double-blind, placebo-controlled primary prevention trial, 
tested the efﬁ  cacy of supplementation with a combination 
of antioxidant vitamins and minerals, at nutritional doses, 
in reducing the incidence of cancer in a general population 
not selected for risk factors (Hercberg et al 2004). After a 
7.5-year follow-up, antioxidant supplementation was 
associated with a reduction in cancer incidence in men only. 
However, Authors discussed that antioxidant supplementa-
tion may have beneﬁ  cial effects on cancer incidence only 
in healthy subjects, who are not exposed to cancer risk, and 
with a particularly low baseline antioxidant levels (Hercberg 
et al 2006). Authors also warned that high dosage antioxi-Clinical Interventions in Aging 2007:2(3) 383
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dant supplementation 1) may be deleterious in subjects in 
whom an initial phase of carcinogenesis has already started, 
and 2) could be ineffective in well-nourished subjects with 
adequate antioxidant status (Hercberg et al 2006). Consis-
tent with these ﬁ  ndings, a trial aimed at evaluating the lung 
cancer incidence showed that selenium supplementation 
was beneﬁ  cial only among individuals with low baseline 
selenium concentrations (Reid et al 2002).
In the cancer prevention study II nutrition cohort, the 
authors examined the association between multivitamin 
supplementation and incidence of colorectal cancer (Jacobs 
et al 2003). Results were consistent with the hypothesis that 
past, but not recent, multivitamin use may be associated with 
a modest lower risk of colorectal cancer.
A recent review of randomised trials comparing 
antioxidant supplements to placebo/no intervention for the 
incidence of gastrointestinal cancers has found no evidence 
that antioxidant supplements prevent gastrointestinal can-
cers (Bjelakovic et al 2004). On the other hand, antioxidant 
supplements seem to increase overall mortality. Similarly to 
what obtained for the cardiovascular disease outcome, Pham 
and Plakogiannis (Pham and Plakogiannis 2005) found no 
sufﬁ  cient evidence that vitamin E is able to reduce the risk 
of cancer, concluding that vitamin E supplementation for 
cancer prevention is not recommended.
Physical performance and muscle 
strength
Whether higher antioxidant intake is beneﬁ  cial in promoting 
better physical performance and muscular strength is still 
controversial. Although ﬁ  ndings of some studies have shown 
improvements (Gao et al 2004; Hauer et al 2003; Takanami 
et al 2000; Upritchard et al 2003; Wijnen et al 2001), other 
studies do not support beneﬁ  cial effects of increased anti-
oxidant intakes on physical performance (Avery et al 2003; 
Balakrishnan and Anuradha 1998; Barnett and Conlee 2003; 
Clarkson 1995; Konig et al 2001; Oostenbrug et al 1997; 
Van der Beek 1991). Nevertheless, it seems reasonable an 
adequate antioxidant intake is needed to maintain healthy 
muscular activity (Jackson and Edwards 1990; Maxwell 
1995). It has been suggested that controversial results might 
be explained by the need of better targeting subjects who 
can really beneﬁ  t from antioxidant supplementation (Kris-
Etherton, and for the Nutrition Committee of the American 
Heart Association Council on Nutrition Physical Activity 
and Metabolism 2004). It is likely that only subjects with 
a low antioxidant status (due to an inadequate antioxidant 
intake) or those with high levels of oxidative damage should 
be candidates for an antioxidant supplementation (Patrignani 
et al 2000). To address this issue, it is needed to better explore 
the relationship of dietary antioxidants intake with oxidative 
damage and serum antioxidants levels.
Physical activity
Regarding antioxidants supplementation (eg, vitamin C, 
vitamin E or glutathione) and their potential protective role 
against exercise-related oxidative damage, results are again 
highly inconsistent and/or not adequate, especially in human 
models (Tiidus and Houston 1995). In fact, the relationship 
between oxidative stress and physical activity is still poorly 
understood, particularly in advanced age, since limited data 
are still available regarding the effects of acute exercise and 
training in elderly subjects. Moreover, available studies are 
characterized by low number of subjects, different types and 
intensities of exercise, and not homogeneous or not com-
pletely reliable methods of oxidative damage measurements. 
Therefore, the paradox of physical activity (which is certainly 
beneﬁ  cial at all ages, but simultaneously potentially harmful 
if not adequately performed due to the free radical excessive 
production) can not be clariﬁ  ed at the present time.
Since the several current guidelines recommend regu-
lar physical activity in the older persons (Department of 
Health and Human Services, Centers for Disease Control 
and Prevention, and National Center for Chronic Disease 
Prevention and Health Promotion 1996; Pate et al 1995), 
further studies are urgently required to better assess the 
potential effects of exercise-related free radicals production 
during exercise.
Longevity
Nutritional supplementation, especially with antioxidants, 
has been frequently indicated as a potential mean to improve 
health status and increase longevity (Harman 1962). How-
ever, only limited evidence about the protective effects of 
speciﬁ  c micronutrients is available. Moreover, it is still 
unclear whether the health beneﬁ  ts from diets at high con-
sumption of fruit and vegetables (van Poppel and van den 
Berg 1997) can be replicated by antioxidant supplementa-
tions (Potter 1997).
The theoretical basis supporting a possible relationship 
between antioxidant supplementation and longevity are 
mainly from the evidence showing a relationship of the latter 
with the rate of mitochondrial oxygen radical generation and 
the degree of unsaturation of membrane fatty acids (Barja 
2002). In fact, these two molecular traits are signiﬁ  cantly 
lower in all the relatively long-lived homeothermic verte-Clinical Interventions in Aging 2007:2(3) 384
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brates, and may be main causes of the low rate of aging of 
long-lived animals.
In an animal model, Lipman and colleagues (Lipman 
et al 1998) showed no effect on age-associated lesions pat-
terns, lesion burden or longevity in ad libitum mice fed with 
a the diet supplemented with antioxidants (vitamin E and 
glutathione) and initiated during middle age. Results from 
the SU.VI.MAX study (Hercberg et al 2004), consistently 
with ﬁ  ndings obtained on incidence of cancer, showed a 
possible protection for overall mortality in men enrolled in 
the intervention group. However, no deﬁ  nite conclusion was 
provided by Authors regarding this possible association, but 
the recommendation of a lifelong diversiﬁ  ed diet including 
an abundance of foods rich in antioxidant nutrients as previ-
ously proposed (Drewnowski et al 1997).
A great interest has been attracted by the potential capacity 
of melatonin to extend life span (Anisimov 2003). Melatonin 
is a potent free radical scavenger, especially towards highly 
toxic hydroxyl radicals. Moreover, melatonin additionally 
stimulates a number of antioxidative enzymes (Reiter 1998). 
Unfortunately, current data do not still allow to conclude that 
melatonin may have a role in extending normal longevity. 
Moreover, as for many other antioxidants, melatonin can act 
as a prooxidant under certain conditions (Anisimov 2003; 
Clapp-Lilly et al 2001; Osseni et al 2000).
Antioxidant supplementation issues
A major limitation of current literature resides in the still 
limited knowledge of oxidative mechanisms and the lack 
of valid biochemical markers evaluating the candidate 
antioxidant compounds. It has also been suggested that 
antioxidant treatment may need to begin earlier in life to be 
effective (Kris-Etherton, and for the Nutrition Committee 
of the American Heart Association Council on Nutrition 
Physical Activity and metabolism 2004). The discrepancy 
between the impressive observational data and the clinical 
trials could also be due to the difference between lifelong 
exposures to an antioxidant-rich diet versus a limited expo-
sure to antioxidant supplements (ie, the trails follow-up). 
Moreover, several other potential explanations should be 
considered when analyzing the lack of agreement between 
the predicted positive beneﬁ  ts and the results of the clinical 
trials conducted to date. For example, it may be that only 
particular antioxidants (possibly in combination with others) 
might exert protective effects on clinical or biological condi-
tions, or that only speciﬁ  c populations might beneﬁ  t from 
an antioxidant supplementation (ie, only subjects with low 
antioxidant and/or high oxidative stress levels).
An important part of the evidence supporting the 
beneﬁ  cial effects of antioxidant supplementation is based on 
animal data. Results from these studies need to be considered 
cautiously. In fact, even if these experiments are crucial in the 
understanding of mechanisms at the basis of biological and 
clinical hypothesis, the translation of their results to humans 
may sometimes be problematic and/or misleading.
As for any other medication/intervention, antioxidant 
supplementation is likely to present its own “therapeutic 
window”. In other words, there might be an optimal early tim-
ing after the initial reactive oxygen species production during 
which supplementation may still have a “preventive effect”. 
Then, it should be also considered that each antioxidant may 
present a speciﬁ  c and peculiar timing, the combination of 
antioxidants may modify the “therapeutic window”, and/or 
the length of exposure to supplementation may play a crucial 
role for the achievement of the effects.
The doses that are required to achieve a therapeutic effect 
are not deﬁ  nitively determined and represent another issue 
that needs to be addressed. The belief that if enough of an 
essential nutrient is good, then more is better is wide spread. 
Nevertheless, this may not be true. For example, zinc supple-
ments using doses >50 mg/day have been associated with 
depressed immune response (Chandra and McBean 1994), 
and chronic exposure to selenium compounds is associated 
with several adverse health effects (Vinceti et al 2001).
Even if some epidemiological studies shown that antiox-
idant supplementation may decrease the risk of several clini-
cal conditions, such observations are usually not universal 
(Butler et al 2002). Even the only capability of reducing 
oxidative damage through antioxidant supplementation is 
limited. For example, Mc Call and Frei stated that “except 
for supplemental vitamin E, and possibly vitamin C, being 
able to signiﬁ  cantly lower lipid oxidative damage in both 
smokers and non-smokers, the current evidence is insuf-
ﬁ  cient to conclude that antioxidant vitamin supplementation 
materially reduces oxidative damage in humans” (McCall 
and Frei 1999). The further step of assessing whether the 
modiﬁ  cation of a biological mechanism (eg, decrease of 
lipid oxidative damage levels) is able to provide a clinical 
beneﬁ  t (eg, reduction of cardiovascular events) is still far 
to be ascertained.
In conclusion, current evidence does not allow to 
recommend antioxidant supplementation as a useful mean 
to prevent age-related pathophysiological modiﬁ  cations and 
clinical conditions. Several concerns are present not only about 
their efﬁ  cacy, but also on their safety. No recommendation will 
be made until a clearer picture of 1) mechanisms underlying Clinical Interventions in Aging 2007:2(3) 385
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the aging process, 2) the network existing among the different 
antioxidant molecules, 3) the relationship between pro-oxidant 
and antioxidant factor, 4) the pathogenesis of the oxidative 
damage-related disease, and 5) reliable markers of oxidant 
and antioxidant levels, will be provided.
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